Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A short bolus infusion of fluid, called "fluid challenge" is commonly recommended for fluid treatment during longer surgery. However a prolonged increase of the blood volume is a prerequisite to recommend the technique. The purpose with the study is to examine the plasma expanding effect of three different fluid challenge strategies (acetated Ringers 4 ml/kg body weight, albumin 5% 4 ml/kg body weight or albumin 20% 1 ml/kg body weight), using hemoglobin as a dilution indicator.
60 patients scheduled for laparoscopic abdominal surgery, with a duration exceeding 90 minutes will be included in the study. These are randomized to three different groups (20 in each groups): The first group of patients will receive boluses of acetated Ringers 4 ml/kg body weight. The second albumin 4 ml/kg body weight and the third group albumin 20% 1 ml/kg body weight.
Hemoglobin, albumin and colloid osmotic pressure (COP) is sampled the day before surgery and in the morning directly prior to the anesthesia. Bioimpedance, urine osmolality and urine-creatinin are also measured. After induction of surgery a Cardio Q probe is inserted threw the nose into the esophagus, for circulatory measurements. Initial/baseline blood samples are taken after insufflation of carbon dioxide to the abdomen. Before every bolus of fluid and 5, (10), 15, 20, 30, 40, (50) and (60) minutes new blood samples are taken for determination of hemoglobin, albumin and COP. Artery blood gases are sampled 15 minutes after every infusion or depending on the clinical need.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| acetated Ringers | Experimental | The circulatory effect of a bolus infusion with 4 ml/kg body weight of acetated Ringers will be studied. If cardiac output increase with 10% a second bolus will be infused and further studied. |
|
| albumin 5% | Experimental | The circulatory effect of a bolus infusion with 4 ml/kg body weight of Albumin 5% will be studied. If cardiac output increases with 10% a second bolus will be infused and further studied. |
|
| albumin 20% | Experimental | The circulatory effect of a bolus infusion with 1 ml/kg body weight of Albumin 20% will be studied. If cardiac output increase with 10% a second bolus will be infused and further studied. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| acetated Ringers | Drug | After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first fluid bolus is infused. Circulatory and volume effects are studied. If cardiac output increase a second bolus is infused and studied. |
| Measure | Description | Time Frame |
|---|---|---|
| Plasma volume expansion after a fluid bolus | Plasma volume using hemoglobin as an indicator of dilution | 60 minutes after an intravenous fluid bolus |
| Measure | Description | Time Frame |
|---|---|---|
| Fluid Balance | Calculations of fluid balance | 18 to 24 hours |
| Stroke Volume | Change in stroke volume, measured with Cardio Q (oesophageal Doppler monitoring (ODM)) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Robert Svensson, MD | Contact | +4610142305 | robert.svensson@regionostergotland.se | |
| Hans Bahlmann, MD, PhD | Contact | +46101031860 | hans.bahlmann@regionostergotland.se |
| Name | Affiliation | Role |
|---|---|---|
| Joachim Zdolsek, MD PhD | Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Vrinnevi Hospital | Recruiting | Norrköping | Östergötland County | 60379 | Sweden |
Individual de-identified results will be shared, when results are published.
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Jul 1, 2022 | Jan 28, 2023 | Prot_000.pdf |
| SAP | No | Yes | No | Statistical Analysis Plan | Jul 1, 2022 | Feb 9, 2023 | SAP_001.pdf |
Not provided
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D014571 | Urologic Neoplasms |
| D009369 | Neoplasms |
| ID | Term |
|---|---|
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
| ID | Term |
|---|---|
| C028570 | Ringer's acetate |
| C067831 | zidovudine 5'-monophosphate-mannose-albumin conjugate |
| D000418 | Albumins |
| C525853 | galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20 |
| ID | Term |
|---|---|
| D011506 | Proteins |
| D000602 | Amino Acids, Peptides, and Proteins |
Not provided
Not provided
3 randomized parallel groups, with 20 patients in each group. Each group receives a prespecified fluid regime with: 1. acetated Ringers 2. albumin 5% or 3. albumin 20%
Not provided
Not provided
Not provided
Not provided
|
| albumin 5% | Drug | After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied. |
|
|
| albumin 20% | Drug | After insufflation of carbon dioxide during an abdominal laparoscopic procedure, the first bolus of fluid is infused. Circulatory and volume effects are studied. If cardiac output increases a second bolus is infused and studied. |
|
|
| 60 minutes after an intravenous fluid bolus |
| Arterial Blood Pressure | Mean Arterial Pressure, measured with an arterial line. | 60 minutes after an intravenous fluid bolus |
| Heart Rate | Heart rate, measured with ECG and pulseoximeter. | 60 minutes after an intravenous fluid bolus |
| Bioimpedance | Bioimpedance measures, resistance and impedance converted to volume of body fluid compartments. | 18 to 24 hours |
| Serum Creatinin | Serum Creatinin as a measure of kidney function | 18 to 24 hours |
| arterial pH | Influence of a fluid bolus on arterial blood gases | 60 minutes after an intravenous fluid bolus |
| arterial Base Excess | Influence of a fluid bolus on arterial blood gases | 60 minutes after an intravenous fluid bolus |
| arterial serum sodium | Influence of a fluid bolus on Sodium concentration | 60 minutes after an intravenous fluid bolus |
| arterial serum chloride | Influence of a fluid bolus on Chloride concentrations | 60 minutes after an intravenous fluid bolus |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D003108 | Colonic Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
| D014565 | Urogenital Neoplasms |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D014570 | Urologic Diseases |